ReleaseWire

An investigation on behalf of investors of LKQ Corporation (NASDAQ:LKQ) shares over potential securities laws violations by LKQ Corporation and certain of its directors and officers in connection certain financial statements was announced.

“There are a number of different answers to that question,” replied Clelland Green, RHU, CEO, Benenapth.net in Pennsylvania, “and there is no right or wrong answer. This is because the answer is strictly personal to each insurance agent. So what works for one might not work for another.”

An investigation on behalf of investors of United Therapeutics Corporation (NASDAQ:UTHR) shares over potential securities laws violations by United Therapeutics Corporation and certain of its directors and officers in connection certain financial statements was announced .

Reportstack, provider of premium market research reports announces the addition of Warts - Pipeline Review, H2 2013 market report to its offering Warts - Pipeline Review, H2 2013

Reportstack, provider of premium market research reports announces the addition of Intermittent Claudication - Pipeline Review, H2 2013 market report to its offering Intermittent Claudication - Pipeline Review, H2 2013

Reportstack, provider of premium market research reports announces the addition of Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2013 market report to its offering Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2013

Reportstack, provider of premium market research reports announces the addition of Gaucher's Disease - Pipeline Review, H2 2013 market report to its offering Gaucher's Disease - Pipeline Review, H2 2013

Reportstack, provider of premium market research reports announces the addition of Skin Infections - Pipeline Review, H2 2013 market report to its offering Skin Infections - Pipeline Review, H2 2013

Reportstack, provider of premium market research reports announces the addition of Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2013 market report to its offering Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2013

Reportstack, provider of premium market research reports announces the addition of Hyperalgesia - Pipeline Review, H2 2013 market report to its offering Hyperalgesia - Pipeline Review, H2 2013

Reportstack, provider of premium market research reports announces the addition of Cancer Cachexia - Pipeline Review, H2 2013 market report to its offering Cancer Cachexia - Pipeline Review, H2 2013

Reportstack, provider of premium market research reports announces the addition of Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2013 market report to its offering Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2013

Reportstack, provider of premium market research reports announces the addition of Fragile X Syndrome - Pipeline Review, H2 2013 market report to its offering Fragile X Syndrome - Pipeline Review, H2 2013

Reportstack, provider of premium market research reports announces the addition of Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H2 2013 market report to its offering Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H2 2013

Reportstack, provider of premium market research reports announces the addition of Anthrax - Pipeline Review, H2 2013 market report to its offering Anthrax - Pipeline Review, H2 2013

Reportstack, provider of premium market research reports announces the addition of Allergic Asthma - Pipeline Review, H2 2013 market report to its offering Allergic Asthma - Pipeline Review, H2 2013

Reportstack, provider of premium market research reports announces the addition of Staphylococcus Aureus Infections - Pipeline Review, H2 2013 market report to its offering Staphylococcus Aureus Infections - Pipeline Review, H2 2013

Reportstack, provider of premium market research reports announces the addition of Burkholderia Infections - Pipeline Review, H2 2013 market report to its offering Burkholderia Infections - Pipeline Review, H2 2013

Reportstack, provider of premium market research reports announces the addition of Domainex Ltd. - Product Pipeline Review - 2013 market report to its offering Domainex Ltd. - Product Pipeline Review - 2013

Reportstack, provider of premium market research reports announces the addition of EpiZyme, Inc. - Product Pipeline Review - 2013 market report to its offering EpiZyme, Inc. - Product Pipeline Review - 2013

Reportstack, provider of premium market research reports announces the addition of Molecular Partners AG - Product Pipeline Review - 2013 market report to its offering Molecular Partners AG - Product Pipeline Review - 2013

Reportstack, provider of premium market research reports announces the addition of Toray Industries, Inc. - Product Pipeline Review - 2013 market report to its offering Toray Industries, Inc. - Product Pipeline Review - 2013

Reportstack, provider of premium market research reports announces the addition of Basilea Pharmaceutica AG - Product Pipeline Review - 2013 market report to its offering Basilea Pharmaceutica AG - Product Pipeline Review - 2013

Reportstack, provider of premium market research reports announces the addition of WhanIn Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013 market report to its offering WhanIn Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013

Reportstack, provider of premium market research reports announces the addition of Artielle ImmunoTherapeutics, Inc. - Product Pipeline Review - 2013 market report to its offering Artielle ImmunoTherapeutics, Inc. - Product Pipeline Review - 2013